Back to Search
MEGHAN COGHLAN, M.D.
M.D.
Neonatal-Perinatal Medicine Physician
NPI: 1609045962Individual
Specialties, Licenses & Credentials
Neonatal-Perinatal Medicine PhysicianPrimary
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
2009011802(MO)
Pediatrics Physician
Pediatrics
Code: 208000000X
2009011802(MO)
Research & Publications (20)
Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells.
PMID 18922131·Biochem J·2009
7-preclinical
An intra/intermolecular suzuki sequence to benzopyridyloxepines containing geometrically pure exocyclic tetrasubstituted alkenes.
PMID 18537249·Org Lett·2008
8-other
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
PMID 17973362·J Med Chem·2007
7-preclinical
Cyclocarbopalladation of alkynes: a stereoselective method for preparing dibenzoxapine containing tetrasubstituted exocyclic alkenes.
PMID 16597141·Org Lett·2006
8-other
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats.
PMID 16921397·Br J Pharmacol·2006
7-preclinical
Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs.
PMID 16487510·Eur J Pharmacol·2006
7-preclinical
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
PMID 17154517·J Med Chem·2006
7-preclinical
Small molecule glucokinase activators as novel anti-diabetic agents.
PMID 15787609·Biochem Soc Trans·2005
6-review
Introduction to the Kinases in Diabetes Biochemical Society Focused Meeting: are protein kinases good targets for antidiabetic drugs?
PMID 15787601·Biochem Soc Trans·2005
7-preclinical
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892.
PMID 15302680·Br J Pharmacol·2004
7-preclinical
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.
PMID 15163197·J Med Chem·2004
7-preclinical
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
PMID 14698167·Bioorg Med Chem Lett·2004
7-preclinical
ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
PMID 15277581·J Pharmacol Exp Ther·2004
7-preclinical
Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators.
PMID 15026058·Bioorg Med Chem Lett·2004
4-observational
Structure-activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as K(ATP) channel openers.
PMID 15051058·Bioorg Med Chem·2004
7-preclinical
Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators.
PMID 14988235·Diabetes·2004
7-preclinical
Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
PMID 15375789·Metabolism·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1465 S GRAND BLVD
SAINT LOUIS, MO 63104 - Phone
- (314) 577-5642
Quick Facts
- NPI
- 1609045962
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile